Treatment options for benign prostatic hyperplasia in older men
- PMID: 18591930
Treatment options for benign prostatic hyperplasia in older men
Abstract
Background: Benign prostatic enlargement (BPE) is one of the most common diseases in ageing men; it is associated with bothersome lower urinary tract symptoms that affect the individual's quality of life. This review focuses on the different available options for treating benign prostatic hyperplasia (BPH) in older men and on how to choose the right treatment.
Material/methods: A literature search was done to review relevant papers. Relatively recent papers, as well as those in a series or papers from expert centers, are included in the reference list.
Results: Treatment options for BPE in older men include medical therapy, transurethral resection of the prostate (TURP), minimally invasive treatments (ie, transurethral microwave thermotherapy, transurethral needle ablation, and laser surgery) and prostatic stenting. Age, individual anesthesiologic risk, grade of obstruction, prostate volume, serum prostate specific antigen (PSA) value, treatment-related complication rate, presence of an indwelling catheter, and neurologic disorders are factors that should be taken into consideration in choosing an appropriate treatment.
Conclusions: Given the wealth of treatment options available, physicians must take care to choose the right treatment for each patient, depending on the patient's needs and medical history.
Similar articles
-
Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.J Urol. 2007 Mar;177(3):1047-51; discussion 1051. doi: 10.1016/j.juro.2006.10.042. J Urol. 2007. PMID: 17296409
-
An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.BJU Int. 2006 May;97(5):1007-16. doi: 10.1111/j.1464-410X.2005.06089.x. Epub 2006 Mar 17. BJU Int. 2006. PMID: 16542339
-
Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life.Int J Clin Pract. 2005 May;59(5):579-90. doi: 10.1111/j.1368-5031.2005.00531.x. Int J Clin Pract. 2005. PMID: 15857355 Review.
-
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.Clin Ther. 2006 Jan;28(1):13-25. doi: 10.1016/j.clinthera.2006.01.004. Clin Ther. 2006. PMID: 16490576 Review.
-
Transurethral needle ablation of the prostate.Curr Opin Urol. 2007 Jan;17(1):7-11. doi: 10.1097/MOU.0b013e328011ab98. Curr Opin Urol. 2007. PMID: 17143104 Review.
Cited by
-
A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia.Curr Bladder Dysfunct Rep. 2015;10(2):186-192. doi: 10.1007/s11884-015-0296-5. Curr Bladder Dysfunct Rep. 2015. PMID: 25984251 Free PMC article. Review.
-
Inhibitory action of Epilobium hirsutum extract and its constituent ellagic acid on drug-metabolizing enzymes.Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):109-16. doi: 10.1007/s13318-014-0238-1. Epub 2014 Nov 26. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25425117
-
Is Prostate Urethral Lift Effective in Patients with Multiple Comorbidities?J Clin Med. 2022 Mar 30;11(7):1928. doi: 10.3390/jcm11071928. J Clin Med. 2022. PMID: 35407535 Free PMC article.
-
Ahead of the curve.Popul Health Manag. 2013;16 Suppl 1:S1. doi: 10.1089/pop.2013.1682. Popul Health Manag. 2013. PMID: 24070242 No abstract available.
-
Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients.Radiol Med. 2015 Apr;120(4):361-8. doi: 10.1007/s11547-014-0447-3. Epub 2014 Sep 23. Radiol Med. 2015. PMID: 25245496
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous